Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer

Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer

It remains unclear whether hepatocellular carcinoma (HCC) recurrence in hepatitis C virus (HCV)-infected patients can be suppressed by the elimination of the virus using direct-acting antivirals (DAAs) after radical HCC treatment. We evaluated the sustained inhibitory effect of DAAs on HCC recurrenc...

Full description

Bibliographic Details
Main Authors: Arinaga-Hino, T. (Author), Ide, T. (Author), Iwamoto, H. (Author), Kamachi, N. (Author), Koga, H. (Author), Kuromatsu, R. (Author), Kuwahara, R. (Author), Nakano, M. (Author), Niizeki, T. (Author), Noda, Y. (Author), Okamura, S. (Author), Shimose, S. (Author), Shirachi, M. (Author), Shirono, T. (Author), Takaki, H. (Author), Torimura, T. (Author), Zaizen, Y. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
direct-acting antiviral
hepatic resection
hepatitis C virus
hepatocellular carcinoma
propensity score matching
radiofrequency ablation
recurrence
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items